Further evaluation of Vigabatrin therapy in 4-hydroxybutyric aciduria.
Jakobs
C
C
Michael
T
T
Jaeger
E
E
Jaeken
J
J
Gibson
K M
KM
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors*; D000445:Aldehyde Oxidoreductases / Q000172:deficiency*; D000592:Amino Acid Metabolism, Inborn Errors / Q000188:drug therapy*; D000614:Aminocaproates / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D012978:Sodium Oxybate / Q000652:urine; D050644:Succinate-Semialdehyde Dehydrogenase; D020888:Vigabatrin
D000614:Aminocaproates; D012978:Sodium Oxybate; D000445:Aldehyde Oxidoreductases; C493643:ALDH5A1 protein, human; D050644:Succinate-Semialdehyde Dehydrogenase; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin